Send me a link:

*Text messaging rates may apply.

 Dow Down0.42% Nasdaq Down0.39%

Momenta Pharmaceuticals Inc. (MNTA)

-NasdaqGS
10.71 Up 0.07(0.66%) Aug 1, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 10,785   12,749   10,752   4,361  
Cost of Revenue -   -   -   -  
Gross Profit 10,785   12,749   10,752   4,361  
Operating Expenses
Research Development26,692  32,228  27,445  21,994  
Selling General and Administrative11,717  10,855  8,969  11,517  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (27,624) (30,334) (25,662) (29,150)
Income from Continuing Operations
Total Other Income/Expenses Net262  273  280  301  
Earnings Before Interest And Taxes(27,362)(30,061)(25,382)(28,849)
Interest Expense -   -   -   -  
Income Before Tax(27,362)(30,061)(25,382)(28,849)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(27,362)(30,061)(25,382)(28,849)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (27,362) (30,061) (25,382) (28,849)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (27,362) (30,061) (25,382) (28,849)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.